Hikari Power LTD Corcept Therapeutics Inc Transaction History

Hikari Power LTD

  • $1.11 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$11.0 - $18.26 $184,690 - $306,585
-16,790 Closed
0 $0
Q2 2019

Aug 08, 2019
BUY
$9.78 - $12.76 $164,206 - $214,240
16,790 New
16,790 $187,000
Q3 2018

Oct 31, 2018
SELL
$12.27 - $15.65 $368,100 - $469,500
-30,000 Closed
0 $0
Q2 2018

Aug 02, 2018
BUY
$15.3 - $19.69 $459,000 - $590,700
30,000 New
30,000 $472,000

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.95B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Hikari Power LTD Portfolio

Follow Hikari Power LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

News

Stay updated on Hikari Power LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email